China Injectable Drug Delivery Devices Market Growth, Size, Share, Demand and Opportunities 2032
China Injectable Drug Delivery Devices Market Size- By Type of Devices, By Therapeutic Application, By Usage Pattern, By Site of Delivery- Regional Outlook, Competitive Strategies and Segment Forecast to 2032
| Published: Feb-2023 | Report ID: MEDE2306 | Pages: 1 - 103 | Formats*: |
| Category : Medical Devices | |||
China Injectable Drug Delivery Devices Market Overview
According to SPER Market Research, the China Injectable Drug Delivery Devices Market is estimated to reach USD 235.46 billion by 2032 with a CAGR of 18.23%.
The delivery and transportation of therapeutic medicine to a patient's body is accomplished using injectable devices. The equipment used to deliver injectable drugs comes in a wide variety, including traditional syringes, needle-free injectors, auto-injectors, and pen injectors. Devices for subcutaneous drug delivery are used to treat a variety of chronic and infectious disorders. In this, the medicinal medications are injected using a syringe into the layer between muscles and tissues. Compared to direct injection into veins, absorption happens more slowly.
The market for injectable drug delivery devices is predicted to grow more rapidly in the near future. It is due to the increase in public awareness and significant financial investments in medical infrastructure.
Impact of COVID-19 on the China Injectable Drug Delivery Devices Market
Covid-19 is a highly contagious illness that mostly affects people's respiratory systems. The covid19 is affecting people all throughout the world. With the exception of the pharmaceutical industry, it has had a negative impact on the operation of every industry. There is an increased need for ventilators, testing supplies, medications, vaccines, and oxygen cylinders compared to before the global pandemic. The demand for injectable devices and other healthcare products increased last year, which led to a boom in the market for injectable medication delivery devices. Every country's government devotes a significant portion of its financial resources to acquiring and producing additional pharmaceuticals and medical supplies. People are becoming immunized all throughout the world. The market for injectable medicine delivery methods is growing as a result.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2032 |
| Base year considered | 2021 |
| Forecast period | 2022-2032 |
| Segments covered | By Type of Devices, By Therapeutic Application, By Usage Pattern, By Site of Delivery |
| Regions covered | North China, Northeast China, East China, South China, Central China, Southwest China, Northwest China. |
| Companies Covered | Baxter, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Gerresheimer AG, GSK plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd. |
China Injectable Drug Delivery Devices Market Segmentation:
1. By Type of Devices:
- Conventional Injection Devices
- Self-Injection Devices
2. By Therapeutic Application:
- Autoimmune Diseases
- Hormonal Disorders
- Cancer
3. By Usage Pattern:
- Curative pattern
- Immunization
4. By Site of Delivery:
- Intramuscular
- Subcutaneous
- Intra Dermal
5. By Region:
- North China
- Northeast China
- East China
- South China 
- Central China
- Southwest China
- Northwest China
Key Topics Covered in the Report:
- Size of China Injectable Drug Delivery Devices Market (FY’2019-FY’2032)
- Overview of China Injectable Drug Delivery Devices Market
- Segmentation of China Injectable Drug Delivery Devices By Type of Devices (Conventional Injection Devices, Self-Injection Devices)
- Segmentation of China Injectable Drug Delivery Devices Market By Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Cancer)
- Segmentation of China Injectable Drug Delivery Devices Market By Usage Pattern (Curative pattern, Immunization)
- Segmentation of China Injectable Drug Delivery Devices By Site of Delivery (Intramuscular, Subcutaneous, Intra Dermal)
- Statistical Snap of China Injectable Drug Delivery Devices Market
- Growth Analysis of China Injectable Drug Delivery Devices Market
- Problems and Challenges in China Injectable Drug Delivery Devices Market
- Competitive Landscape in the China Injectable Drug Delivery Devices Market
- Impact of COVID-19 and Demonetization on China Injectable Drug Delivery Devices Market
- Details on Recent Investment in China Injectable Drug Delivery Devices Market
- Competitive Analysis of China Injectable Drug Delivery Devices Market
- Major Players in the China Injectable Drug Delivery Devices Market
- SWOT Analysis of China Injectable Drug Delivery Devices Market
- China Injectable Drug Delivery Devices Market Future Outlook and Projections (FY’2019-FY’2032)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data2.1.2 Primary data2.1.3 SPER’s internal database2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints4.1.3 Opportunities4.1.4 Challenges
4.2. COVID-19 Impacts of the China Injectable Drug Delivery Devices Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths5.1.2 Weaknesses5.1.3 Opportunities5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape5.2.2 Economic landscape5.2.3 Social landscape5.2.4 Technological landscape5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers5.3.2 Bargaining power of Buyers5.3.3 Threat of Substitute5.3.4 Threat of new entrant5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Competitive Landscape
6.1 China Injectable Drug Delivery Devices Manufacturing Base Distribution, Sales Area, Product Type6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in China Injectable Drug Delivery Devices Market
7. China Injectable Drug Delivery Devices Market, By Type of Devices, 2019-2032 (USD Million)
7.1. Conventional Injection Devices7.2. Self-Injection Devices
8. China Injectable Drug Delivery Devices Market, By Therapeutic Application, 2019-2032 (USD Million)
8.1. Autoimmune Diseases8.2. Hormonal Disorders8.3. Cancer
9. China Injectable Drug Delivery Devices Market, By Usage Pattern, 2019-2032 (USD Million)
9.1. Curative pattern9.2. Immunization
10. China Injectable Drug Delivery Devices Market, By Site of Delivery, 2019-2032 (USD Million)
10.1. Intramuscular10.2. Subcutaneous10.3. Intra Dermal
11. China Injectable Drug Delivery Devices Market, By Region, 2019-2032 (USD Million)
11.1. China Injectable Drug Delivery Devices Market Size and Market Share by Region (2019-2025)11.2. China Injectable Drug Delivery Devices Market Size and Market Share by Region (2026-2032)11.3. North China11.4. Northeast China11.5. East China11.6. South China 11.7. Central China11.8. Southwest China11.9. Northwest China
12. Company Profiles
12.1. Baxter
12.1.1. Company details12.1.2. Financial outlook12.1.3. Product summary12.1.4. Recent developments
12.2. Becton
12.2.1. Company details12.2.2. Financial outlook12.2.3. Product summary12.2.4. Recent developments
12.3. Dickinson and Company
12.3.1. Company details12.3.2. Financial outlook12.3.3. Product summary12.3.4. Recent developments
12.4. F. Hoffmann-La Roche AG
12.4.1. Company details12.4.2. Financial outlook12.4.3. Product summary12.4.4. Recent developments
12.5. Gerresheimer AG
12.5.1. Company details12.5.2. Financial outlook12.5.3. Product summary12.5.4. Recent developments
12.6. GSK plc
12.6.1. Company details12.6.2. Financial outlook12.6.3. Product summary12.6.4. Recent developments
12.7. Merck & Co. Inc.
12.7.1. Company details12.7.2. Financial outlook12.7.3. Product summary12.7.4. Recent developments
12.8. Novartis AG
12.8.1. Company details12.8.2. Financial outlook12.8.3. Product summary12.8.4. Recent developments
12.9. Pfizer Inc.
12.9.1. Company details12.9.2. Financial outlook12.9.3. Product summary12.9.4. Recent developments
12.10. Sanofi
12.10.1. Company details12.10.2. Financial outlook12.10.3. Product summary12.10.4. Recent developments
12.11. Teva Pharmaceutical Industries Ltd
12.11.1. Company details12.11.2. Financial outlook12.11.3. Product summary12.11.4. Recent developments
13. List of Abbreviations
14. Reference Links
15. Conclusion
16. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
China Injectable Drug Delivery Devices Market is projected to reach USD 235.46 billion by 2032, growing at a CAGR of 18.23% during the forecast period.
China Injectable Drug Delivery Devices Market grew in market size from 2021. The Market is expected to reach USD 235.46 billion by 2032, at a CAGR of 18.23% during the forecast period.
China Injectable Drug Delivery Devices Market CAGR of 18.23% during the forecast period.
You can get the sample pages by clicking the link - Click Here
China Injectable Drug Delivery Devices Market size is USD 235.46 billion from 2022 to 2032.
China Injectable Drug Delivery Devices Market Segment is Covered By Type of Devices, By Therapeutic Application, By Usage Pattern, By Site of Delivery.
The Asia-Pacific region is anticipated to have the highest market share in the China Injectable Drug Delivery Devices Market.
The key players in the market include Companies Covered Baxter, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Gerresheimer AG, GSK plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd.
The market for injectable drug delivery devices is predicted to grow more rapidly in the near future. It is due to the increase in public awareness and significant financial investments in medical infrastructure.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
